Saul Blecker

机构：NYU Langone Health, New York University · ORCID：0000-0003-4460-1046

发表论文 212 篇 · 总被引 5178 次 · h-index 35

代表论文

• Finerenone Utilization for Chronic Kidney Disease and Diabetes (2026 · JACC Advances · 被引 4)
• A Target Trial Emulation Study of SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Combination Therapy in Preventing Kidney Failure in Type 2 Diabetes (2025 · Clinical Journal of the American Society of Nephrology · 被引 4)
• A Drug-wide Association Study on Medications Associated With Cystatin C–Estimated GFR (2025 · American Journal of Kidney Diseases · 被引 4)
• Schizophrenia, Bipolar, or Major Depressive Disorder and Postacute Sequelae of COVID-19 (2025 · JAMA Network Open · 被引 3)
• Machine learning based prediction of medication adherence in heart failure using large electronic health record cohort with linkages to pharmacy-fill and neighborhood-level data (2025 · Journal of the American Medical Informatics Association · 被引 2)
• Respiratory and Other Infections Following COVID (2025 · PEDIATRICS · 被引 2)